C3 | Clinical Consulting Consortium, founded in 2013 and headquartered in the United States, is a niche Clinical Research Organization (CRO) with a distinguished identity as a woman-owned business. The company thrives on its network of highly experienced Clinical Research Associates (CRAs), offering specialized services across various therapeutic areas.
The firm's unique operating model focuses on quality, efficiency, and flexibility, allowing it to deliver customized, cost-effective solutions. C3's commitment to maintaining a consistent team of seasoned clinical professionals aligns with its core philosophies, reinforcing its reputation within the Analytics, Health Care, Health and Wellness, and Pharmaceutical industries.
Notably, C3 has yet to disclose any recent investment activities. Investors might view this as an opportunity, considering the company's established network and innovative approach in a competitive market poised for growth.